Literature DB >> 16501426

The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies.

Neha Goel1, Anita Tuli, Rewa Choudhry.   

Abstract

BACKGROUND: The present study was undertaken to compare the role of aspirin versus aspirin plus heparin combination in pregnant women with poor obstetric history and raised anticardiolipin antibodies IgG (IgG(acl)). MATERIAL/
METHODS: The study was conducted on 550 pregnant women, 450 with a history of two or more spontaneous abortions forming the study group, while 100 women with one or more live births and no history of abortion were controls. Their blood was tested to assess the level of IgG(acl) by enzyme-linked immunosorbent assay (ELISA). The test was strongly positive in 72 (16%) patients of the study group, who were randomized to receive either low-dose aspirin (80 mg/day) or a combination of low-dose aspirin (80 mg/day) and 5000 IU of unfractionated heparin subcutaneously 12 hourly under hospital surveillance. The pregnancy outcomes were statistically compared.
RESULTS: Of the 39 patients treated with low-dose aspirin, 24 (61.5%) gave birth to live issues compared with 28 (84.8%) of the 33 women given a combination of aspirin and heparin (p<0.05), an overall success rate of 72.2%. Mean birth weight of the babies given treatment with heparin and aspirin was 3.21+/-0.33 kg compared with 2.77+/-0.14 kg achieved with aspirin alone (p<0.001). Both treatments were well tolerated.
CONCLUSIONS: The study provides evidence that in cases of recurrent abortions with raised IgG(acl), treatment with a combination of aspirin and heparin showed better outcome than treatment with aspirin alone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501426

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  17 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.

Authors:  Eva N Hamulyák; Luuk Jj Scheres; Mauritia C Marijnen; Mariëtte Goddijn; Saskia Middeldorp
Journal:  Cochrane Database Syst Rev       Date:  2020-05-02

Review 3.  Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 4.  Recurrent miscarriage.

Authors:  Kirsten Duckitt; Aysha Qureshi
Journal:  BMJ Clin Evid       Date:  2011-02-01

Review 5.  Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.

Authors:  M Empson; M Lassere; J Craig; J Scott
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

6.  What's new in obstetric antiphospholipid syndrome.

Authors:  D Ware Branch
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 7.  Recurrent miscarriage.

Authors:  Kirsten Duckitt; Aysha Qureshi
Journal:  BMJ Clin Evid       Date:  2008-04-14

8.  Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.

Authors:  Esme V Menezes; Mohammad Yawar Yakoob; Tanya Soomro; Rachel A Haws; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

9.  Increased risk of cardiovascular disease in premenopausal female ragpickers of Eastern India: involvement of inflammation, oxidative stress, and platelet hyperactivity.

Authors:  Nandan Kumar Mondal; Sanghita Roychoudhury; Sayali Mukherjee; Shabana Siddique; Madhuchanda Banerjee; Mark S Slaughter; Twisha Lahiri; Manas Ranjan Ray
Journal:  Mol Cell Biochem       Date:  2016-07-15       Impact factor: 3.396

Review 10.  Aspirin vs Heparin for the Prevention of Preeclampsia.

Authors:  Vasiliki Katsi; Theoni Kanellopoulou; Thomas Makris; Petros Nihoyannopoulos; Efrosyni Nomikou; Dimitrios Tousoulis
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.